Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health concern, particularly in low-resource settings. This article presents an updated approach to the diagnosis and management of enteric fever, incorporating recent advancements in clinical practices and diagnostic methods.
Traditional diagnostic methods, such as blood culture, have been the gold standard for enteric fever diagnosis. However, their sensitivity varies and they require a significant amount of time to yield results. Recent advancements include nucleic acid amplification tests (NAATs) and serological tests like Typhidot and Tubex-TF. NAATs offer high sensitivity and specificity, while serological tests provide rapid results, aiding in early diagnosis. However, the lack of standardization and variable performance of these tests necessitates further research and validation.
Antibiotic therapy remains the mainstay of enteric fever management. The choice of antibiotics should be guided by local antimicrobial resistance patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. However, the emergence of extensively drug-resistant (XDR) strains poses a significant challenge, warranting a judicious use of antibiotics. Supportive care, including hydration and fever management, is also crucial.
Prevention strategies encompass vaccination, safe food and water practices, and improved sanitation. The World Health Organization recommends the use of Typhoid Conjugate Vaccines (TCVs) in endemic areas. However, vaccination should not replace the need for improved water, sanitation, and hygiene practices. Antimicrobial stewardship programs also play a vital role in preventing the emergence and spread of resistant strains.
In conclusion, the diagnosis and management of enteric fever require a multifaceted approach, incorporating advanced diagnostic methods, effective treatment strategies, and robust prevention measures. As the landscape of enteric fever continues to evolve, healthcare professionals must stay updated with the latest practices to ensure optimal patient care and management.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation